标题
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-04
DOI
10.3389/fimmu.2021.765101
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune Checkpoint Inhibitors in the Treatment of HCC
- (2021) Clelia Donisi et al. Frontiers in Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The evolving landscape of immunotherapy in solid tumors
- (2021) Jessica M. Keilson et al. JOURNAL OF SURGICAL ONCOLOGY
- Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis
- (2021) Andrea Casadei‐Gardini et al. LIVER INTERNATIONAL
- Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma
- (2021) Wei Jiang et al. Frontiers in Oncology
- The role of CD133 in hepatocellular carcinoma
- (2021) Fengchao Liu et al. CANCER BIOLOGY & THERAPY
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
- (2021) Xiang-Yuan Luo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Advances in immunotherapy for hepatocellular carcinoma
- (2021) Bruno Sangro et al. Nature Reviews Gastroenterology & Hepatology
- Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study
- (2021) Hui Li et al. Drug Design Development and Therapy
- P-87 Real-world data of nivolumab in advanced hepatocellular carcinoma: A multi-centric and retrospective study
- (2021) M. Sardinha et al. ANNALS OF ONCOLOGY
- O-1 Results from a global phase 2 study of tislelizumab, an investigational PD-1 antibody, in patients with unresectable hepatocellular carcinoma
- (2021) M. Ducreux et al. ANNALS OF ONCOLOGY
- Siglec‐15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44
- (2021) Weitao Liu et al. FEBS LETTERS
- Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
- (2021) Suresh Gopi Kalathil et al. Cells
- Enhancing Chimeric Antigen Receptor T cell Efficacy in Solid Tumors
- (2020) Giovanni Fucá et al. CLINICAL CANCER RESEARCH
- Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
- (2020) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Nivolumab for the treatment of hepatocellular carcinoma
- (2020) Lim Chiew Woon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma
- (2020) Takeshi Terashima et al. HEPATOLOGY RESEARCH
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Editorial: Emerging Concepts on the NKG2D Receptor-Ligand Axis in Health and Diseases
- (2020) Nadia Guerra et al. Frontiers in Immunology
- Immunotherapy for pancreatic cancer: A 2020 update
- (2020) Dimitrios Schizas et al. CANCER TREATMENT REVIEWS
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Liver Cancer Immunity
- (2020) Sumera Rizvi et al. HEPATOLOGY
- Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies
- (2020) Ligong Lu et al. HEPATOLOGY
- Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy
- (2020) Ying Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma
- (2020) Shi-Jie Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
- (2020) Hsiang-chi Tseng et al. Nature Communications
- Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
- (2020) Ying Jing et al. Nature Communications
- Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
- (2020) Christo Kole et al. Cancers
- Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives
- (2020) Piera Federico et al. Cancers
- Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials
- (2020) Seyed Samad Hosseini et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Adoptive cell therapy: Living drugs against cancer
- (2020) Tamara Laskowski et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma
- (2020) Lin Yu et al. JOURNAL OF IMMUNOTHERAPY
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines
- (2019) Mathias Vormehr et al. Annual Review of Medicine
- Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
- (2019) M. Moehler et al. OncoImmunology
- Eradication of Hepatocellular Carcinoma by NKG2D-Specific CAR-T Cells
- (2019) Bin Sun et al. Cancer Immunology Research
- LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
- (2019) T Yau et al. ANNALS OF ONCOLOGY
- Liver-Mediated Adaptive Immune Tolerance
- (2019) Meijuan Zheng et al. Frontiers in Immunology
- The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
- (2019) Peter G. Hendrickson et al. OncoImmunology
- Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
- (2019) Ren-Yu Zhang et al. Frontiers in Cell and Developmental Biology
- Immunotherapy for hepatocellular carcinoma
- (2019) Yin Zongyi et al. CANCER LETTERS
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
- (2019) Yang Liu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
- (2018) Xuexiang Du et al. CELL RESEARCH
- Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
- (2018) Wei Zhu et al. HEPATOLOGY
- Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment
- (2018) Jiansong Wu et al. MEDICINE
- Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
- (2018) Min Yu et al. MOLECULAR THERAPY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Tuning T cell receptor affinity to optimize clinical risk-benefit when targeting α-fetoprotein-positive liver cancer
- (2018) Roslin Y. Docta et al. HEPATOLOGY
- Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein−Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
- (2017) Hidetoshi Nakagawa et al. GASTROENTEROLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- CAR T-cell therapy of solid tumors
- (2017) Carmen S M Yong et al. IMMUNOLOGY AND CELL BIOLOGY
- T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma
- (2017) Weijie Ma et al. Immunotherapy
- Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-β
- (2017) Masataka Sakisaka et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21
- (2017) Maria A. Streltsova et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
- (2017) Fubo Zhou et al. MEDICINAL RESEARCH REVIEWS
- PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes
- (2017) Moufida Ben Nasr et al. Science Translational Medicine
- Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome?
- (2017) Olivera J. Finn et al. Cold Spring Harbor Perspectives in Biology
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
- (2017) Xingchun Gao et al. Frontiers in Immunology
- Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
- (2017) Zhiwu Jiang et al. Frontiers in Immunology
- Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma
- (2017) Xiao-Pu Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
- (2016) Timothy T. Spear et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
- (2016) Hong Liu et al. CLINICAL CANCER RESEARCH
- Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis
- (2016) Haiqing Wang et al. DIGESTIVE AND LIVER DISEASE
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
- (2016) Yu Sawada et al. OncoImmunology
- Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
- (2015) Maria Tagliamonte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma
- (2015) Eishiro Mizukoshi et al. CANCER LETTERS
- Immunological features of T cells induced by human telomerase reverse transcriptase-derived peptides in patients with hepatocellular carcinoma
- (2015) Eishiro Mizukoshi et al. CANCER LETTERS
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
- (2015) Christina Dargel et al. GASTROENTEROLOGY
- TriFabs—Trivalent IgG-Shaped Bispecific Antibody Derivatives: Design, Generation, Characterization and Application for Targeted Payload Delivery
- (2015) Klaus Mayer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
- (2015) Waseem Qasim et al. JOURNAL OF HEPATOLOGY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
- (2015) Shan-Shan Jiang et al. Oncotarget
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Enhanced suppressor function of TIM-3+FoxP3+regulatory T cells
- (2014) Anne-Sophie Gautron et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies
- (2014) Andrew J.S. Furness et al. TRENDS IN IMMUNOLOGY
- NK cells in immunotolerant organs
- (2013) Haoyu Sun et al. Cellular & Molecular Immunology
- Alpha-fetoprotein, a fascinating protein and biomarker in neurology
- (2013) J.H. Schieving et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
- (2013) Jiuwei Cui et al. INTERNATIONAL JOURNAL OF CANCER
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture
- (2012) Alexander Hoh et al. LIVER INTERNATIONAL
- Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity
- (2011) Caroline Jochems et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
- (2011) Kelley A Parato et al. MOLECULAR THERAPY
- Chronic Hepatitis C Infection
- (2011) Hugo R. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer
- (2011) Grazia Graziani et al. PHARMACOLOGICAL RESEARCH
- Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines
- (2010) Adam J. Gehring et al. JOURNAL OF HEPATOLOGY
- Dendritic cells and immunity against cancer
- (2010) K. Palucka et al. JOURNAL OF INTERNAL MEDICINE
- Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma
- (2009) Eishiro Mizukoshi et al. INTERNATIONAL JOURNAL OF CANCER
- A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
- (2008) Daniel H. Palmer et al. HEPATOLOGY
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
- Endolymphatic Immunotherapy in Inoperable Hepatocellular Carcinoma
- (2008) R. Bertelli et al. TRANSPLANTATION PROCEEDINGS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started